Development of cardioplegic solution without potassium: experimental study in rat

Detalhes bibliográficos
Autor(a) principal: Reichert,Karla
Data de Publicação: 2013
Outros Autores: Carmo,Helison Rafael Pereira do, Lima,Fany, Torina,Anali Galluce, Vilarinho,Karlos Alexandre de Souza, Oliveira,Pedro Paulo Martins de, Silveira Filho,Lindemberg Mota, Severino,Elaine Soraya Barbosa de Oliveira, Petrucci,Orlando
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Cardiovascular Surgery (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382013000400018
Resumo: INTRODUCTION: Myocardial preservation during open heart surgeries and harvesting for transplant are of great importance. The heart at the end of procedure has to resume its functions as soon as possible. All cardioplegic solutions are based on potassium for induction of cardioplegic arrest. OBJECTIVE: To assess a cardioplegic solution with no potassium addition to the formula with two other commercially available cardioplegic solutions. The comparative assessment was based on cytotoxicity, adenosine triphosphate myocardial preservation, and caspase 3 activity. The tested solution (LIRM) uses low doses of sodium channel blocker (lidocaine), potassium channel opener (cromakalin), and actin/myosin cross bridge inhibitor (2,3-butanedione monoxime). METHODS: Wistar rats underwent thoracotomy under mechanical ventilation and three different solutions were used for "in situ" perfusion for cardioplegic arrest induction: Custodiol (HTK), Braile (G/A), and LIRM solutions. After cardiac arrest, the hearts were excised and kept in cold storage for 4 hours. After this period, the hearts were assessed with optical light microscopy, myocardial ATP content and caspase 3 activity. All three solutions were evaluated for direct cytotoxicity with L929 and WEHI-164 cells. RESULTS: The ATP content was higher in the Custodiol group compared to two other solutions (P<0.05). The caspase activity was lower in the HTK group compared to LIRM and G/A solutions (P<0.01). The LIRM solution showed lower caspase activity compared to Braile solution (P<0.01). All solutions showed no cytotoxicity effect after 24 hours of cells exposure to cardioplegic solutions. CONCLUSION: Cardioplegia solutions without potassium are promised and aminoacid addition might be an interesting strategy. More evaluation is necessary for an optimal cardioplegic solution development.
id SBCCV-1_37c630876a3302735ab9fde975c65dc6
oai_identifier_str oai:scielo:S0102-76382013000400018
network_acronym_str SBCCV-1
network_name_str Brazilian Journal of Cardiovascular Surgery (Online)
repository_id_str
spelling Development of cardioplegic solution without potassium: experimental study in ratHeart arrest, inducedIschemiaMyocardial ischemiaINTRODUCTION: Myocardial preservation during open heart surgeries and harvesting for transplant are of great importance. The heart at the end of procedure has to resume its functions as soon as possible. All cardioplegic solutions are based on potassium for induction of cardioplegic arrest. OBJECTIVE: To assess a cardioplegic solution with no potassium addition to the formula with two other commercially available cardioplegic solutions. The comparative assessment was based on cytotoxicity, adenosine triphosphate myocardial preservation, and caspase 3 activity. The tested solution (LIRM) uses low doses of sodium channel blocker (lidocaine), potassium channel opener (cromakalin), and actin/myosin cross bridge inhibitor (2,3-butanedione monoxime). METHODS: Wistar rats underwent thoracotomy under mechanical ventilation and three different solutions were used for "in situ" perfusion for cardioplegic arrest induction: Custodiol (HTK), Braile (G/A), and LIRM solutions. After cardiac arrest, the hearts were excised and kept in cold storage for 4 hours. After this period, the hearts were assessed with optical light microscopy, myocardial ATP content and caspase 3 activity. All three solutions were evaluated for direct cytotoxicity with L929 and WEHI-164 cells. RESULTS: The ATP content was higher in the Custodiol group compared to two other solutions (P<0.05). The caspase activity was lower in the HTK group compared to LIRM and G/A solutions (P<0.01). The LIRM solution showed lower caspase activity compared to Braile solution (P<0.01). All solutions showed no cytotoxicity effect after 24 hours of cells exposure to cardioplegic solutions. CONCLUSION: Cardioplegia solutions without potassium are promised and aminoacid addition might be an interesting strategy. More evaluation is necessary for an optimal cardioplegic solution development.Sociedade Brasileira de Cirurgia Cardiovascular2013-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382013000400018Brazilian Journal of Cardiovascular Surgery v.28 n.4 2013reponame:Brazilian Journal of Cardiovascular Surgery (Online)instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)instacron:SBCCV10.5935/1678-9741.20130085info:eu-repo/semantics/openAccessReichert,KarlaCarmo,Helison Rafael Pereira doLima,FanyTorina,Anali GalluceVilarinho,Karlos Alexandre de SouzaOliveira,Pedro Paulo Martins deSilveira Filho,Lindemberg MotaSeverino,Elaine Soraya Barbosa de OliveiraPetrucci,Orlandoeng2014-02-26T00:00:00Zoai:scielo:S0102-76382013000400018Revistahttp://www.rbccv.org.br/https://old.scielo.br/oai/scielo-oai.php||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br1678-97410102-7638opendoar:2014-02-26T00:00Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)false
dc.title.none.fl_str_mv Development of cardioplegic solution without potassium: experimental study in rat
title Development of cardioplegic solution without potassium: experimental study in rat
spellingShingle Development of cardioplegic solution without potassium: experimental study in rat
Reichert,Karla
Heart arrest, induced
Ischemia
Myocardial ischemia
title_short Development of cardioplegic solution without potassium: experimental study in rat
title_full Development of cardioplegic solution without potassium: experimental study in rat
title_fullStr Development of cardioplegic solution without potassium: experimental study in rat
title_full_unstemmed Development of cardioplegic solution without potassium: experimental study in rat
title_sort Development of cardioplegic solution without potassium: experimental study in rat
author Reichert,Karla
author_facet Reichert,Karla
Carmo,Helison Rafael Pereira do
Lima,Fany
Torina,Anali Galluce
Vilarinho,Karlos Alexandre de Souza
Oliveira,Pedro Paulo Martins de
Silveira Filho,Lindemberg Mota
Severino,Elaine Soraya Barbosa de Oliveira
Petrucci,Orlando
author_role author
author2 Carmo,Helison Rafael Pereira do
Lima,Fany
Torina,Anali Galluce
Vilarinho,Karlos Alexandre de Souza
Oliveira,Pedro Paulo Martins de
Silveira Filho,Lindemberg Mota
Severino,Elaine Soraya Barbosa de Oliveira
Petrucci,Orlando
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Reichert,Karla
Carmo,Helison Rafael Pereira do
Lima,Fany
Torina,Anali Galluce
Vilarinho,Karlos Alexandre de Souza
Oliveira,Pedro Paulo Martins de
Silveira Filho,Lindemberg Mota
Severino,Elaine Soraya Barbosa de Oliveira
Petrucci,Orlando
dc.subject.por.fl_str_mv Heart arrest, induced
Ischemia
Myocardial ischemia
topic Heart arrest, induced
Ischemia
Myocardial ischemia
description INTRODUCTION: Myocardial preservation during open heart surgeries and harvesting for transplant are of great importance. The heart at the end of procedure has to resume its functions as soon as possible. All cardioplegic solutions are based on potassium for induction of cardioplegic arrest. OBJECTIVE: To assess a cardioplegic solution with no potassium addition to the formula with two other commercially available cardioplegic solutions. The comparative assessment was based on cytotoxicity, adenosine triphosphate myocardial preservation, and caspase 3 activity. The tested solution (LIRM) uses low doses of sodium channel blocker (lidocaine), potassium channel opener (cromakalin), and actin/myosin cross bridge inhibitor (2,3-butanedione monoxime). METHODS: Wistar rats underwent thoracotomy under mechanical ventilation and three different solutions were used for "in situ" perfusion for cardioplegic arrest induction: Custodiol (HTK), Braile (G/A), and LIRM solutions. After cardiac arrest, the hearts were excised and kept in cold storage for 4 hours. After this period, the hearts were assessed with optical light microscopy, myocardial ATP content and caspase 3 activity. All three solutions were evaluated for direct cytotoxicity with L929 and WEHI-164 cells. RESULTS: The ATP content was higher in the Custodiol group compared to two other solutions (P<0.05). The caspase activity was lower in the HTK group compared to LIRM and G/A solutions (P<0.01). The LIRM solution showed lower caspase activity compared to Braile solution (P<0.01). All solutions showed no cytotoxicity effect after 24 hours of cells exposure to cardioplegic solutions. CONCLUSION: Cardioplegia solutions without potassium are promised and aminoacid addition might be an interesting strategy. More evaluation is necessary for an optimal cardioplegic solution development.
publishDate 2013
dc.date.none.fl_str_mv 2013-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382013000400018
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382013000400018
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/1678-9741.20130085
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
dc.source.none.fl_str_mv Brazilian Journal of Cardiovascular Surgery v.28 n.4 2013
reponame:Brazilian Journal of Cardiovascular Surgery (Online)
instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron:SBCCV
instname_str Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron_str SBCCV
institution SBCCV
reponame_str Brazilian Journal of Cardiovascular Surgery (Online)
collection Brazilian Journal of Cardiovascular Surgery (Online)
repository.name.fl_str_mv Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
repository.mail.fl_str_mv ||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br
_version_ 1752126598442647552